{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-393151","form_type":"8-K","ticker":"TPST","cik":"0001544227","company_name":"Tempest Therapeutics, Inc.","filed_at":"2026-09-16T20:37:26+00:00","discovered_at":"2026-09-16T20:38:01.342099+00:00","generated_at":"2026-09-16T20:38:13.477678+00:00","sec_items":["5.07","8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Tempest's charter amendment vote fails to pass at Sept 15 meeting; reconvenes Oct 14","bullets":["Special meeting reconvened Sept 15, 2026; quorum of 10,760,144 shares (72.7% outstanding) present.","Proposal to replace supermajority voting and allow written consent requires 75% affirmative vote; not achieved.","Meeting adjourned to Oct 14, 2026 at 12:00 pm ET via webcast; record date remains May 28, 2026.","Proxies already submitted will be voted unless revoked; no changes to proposal.","Company engaged Sodali & Co. to assist with proxy solicitation for the vote."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-393151","json":"https://secwatch.observer/filing/0001193125-26-393151.json","markdown":"https://secwatch.observer/filing/0001193125-26-393151.md","text":"https://secwatch.observer/filing/0001193125-26-393151.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1544227/000119312526393151/0001193125-26-393151-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1544227/000119312526393151/d151966d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-16T20:38:13.477678+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}